Ascorbic Acid News and Research

RSS
Abscorbic acid commonly known as Vitamin C is a water-soluble vitamin, which is necessary in the body to form collagen in bones, cartilage, muscle, and blood vessels and aids in the absorption of iron. Dietary sources of vitamin C include fruits and vegetables, particularly citrus fruits such as oranges.

Severe deficiency of vitamin C causes scurvy. Although rare, scurvy includes potentially severe consequences, and can cause sudden death. Patients with scurvy are treated with vitamin C and should be under medical supervision.

Many uses for vitamin C have been proposed, but few have been found to be beneficial in scientific studies. In particular, research in asthma, cancer, and diabetes remains inconclusive, and no benefits have been found in the prevention of cataracts or heart disease.
Bayer Diabetes Care launches DIDGET blood glucose monitoring system in the US

Bayer Diabetes Care launches DIDGET blood glucose monitoring system in the US

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Vitamins touted in skin care products reduce signs of sun-damaged skin: Study

Vitamins touted in skin care products reduce signs of sun-damaged skin: Study

U.S. Census Bureau highlights vitamin C

U.S. Census Bureau highlights vitamin C

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

GeNO's Nitrosyl Delivery Platform IND receives FDA clearance

GeNO's Nitrosyl Delivery Platform IND receives FDA clearance

Storing vitamins in bathrooms and kitchens may degrade their effectiveness

Storing vitamins in bathrooms and kitchens may degrade their effectiveness

Consumption of garlic reduces level of potential carcinogenic processes

Consumption of garlic reduces level of potential carcinogenic processes

FDA Gastrointestinal Drugs Advisory Committee supports approval of XIFAXAN 550 mg for management of HE

FDA Gastrointestinal Drugs Advisory Committee supports approval of XIFAXAN 550 mg for management of HE

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

CONTOUR USB meter available for purchase through Walgreens online pharmacy

CONTOUR USB meter available for purchase through Walgreens online pharmacy

New study reveals the importance of bowel preparation prior to procedure

New study reveals the importance of bowel preparation prior to procedure

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

Lupin grants Salix exclusive rights to its bioadhesive drug delivery technology for use with rifaximin

Levels of vitamin C higher in fruit juices than specified on labels

Levels of vitamin C higher in fruit juices than specified on labels

Optimized diabetes management with the CONTOUR(R) USB blood glucose meter

Optimized diabetes management with the CONTOUR(R) USB blood glucose meter

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis

FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis

Research reveals new protective properties of vitamin C

Research reveals new protective properties of vitamin C

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets